Page last updated: 2024-11-13
salicortin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
salicortin: an aryl glucoside from most species of Salix and Populus; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Related Flora
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Salix | genus | A plant genus of the family Salicaceae. Members contain salicin, which yields SALICYLIC ACID.[MeSH] | Salicaceae | A plant family of the order MALPIGHIALES, superorder ROSANAE, class MAGNOLIOPSIDA. The leaves are alternate and simple, and staminate (male) flowers consist of one to several stamens; pistillate (female) flowers consist of a single-chambered ovary with several ovules that produce silky seeds.[MeSH] |
Cross-References
ID Source | ID |
---|---|
PubMed CID | 38348847 |
CHEBI ID | 137501 |
MeSH ID | M0292172 |
Synonyms (7)
Synonym |
---|
CHEBI:137501 |
salicortin |
HY-123503 |
CS-0082836 |
DTXSID301318465 |
beta-d-glucopyranoside, 2-[[[[(1s)-1-hydroxy-6-oxo-2-cyclohexen-1-yl]carbonyl]oxy]methyl]phenyl |
AKOS040737379 |
Research Excerpts
Overview
Salicortin is a phenolic glycoside that has been isolated from many plants such as Populus and Salix species. It has been shown to have anti-amnesic and anti-adipogenic effects.
Excerpt | Reference | Relevance |
---|---|---|
"Salicortin is a phenolic glucoside produced in Salicaceae as a chemical defense against herbivory. " | ( Acylated Quinic Acids Are the Main Salicortin Metabolites in the Lepidopteran Specialist Herbivore Cerura vinula. Feistel, F; Menezes, RC; Paetz, C; Schneider, B; Veit, D, 2018) | 2.2 |
"Salicortin is a phenolic glycoside that has been isolated from many plants such as Populus and Salix species, and has been shown to have anti-amnesic and anti-adipogenic effects." | ( Salicortin inhibits osteoclast differentiation and bone resorption by down-regulating JNK and NF-κB/NFATc1 signaling pathways. Liu, M; Nie, S; Xu, C; Xu, J; Yu, D; Zhang, C, 2016) | 2.6 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Drug Classes (1)
Class | Description |
---|---|
glycoside | A glycosyl compound resulting from the attachment of a glycosyl group to a non-acyl group RO-, RS-, RSe-, etc. The bond between the glycosyl group and the non-acyl group is called a glycosidic bond. By extension, the terms N-glycosides and C-glycosides are used as class names for glycosylamines and for compounds having a glycosyl group attached to a hydrocarbyl group respectively. These terms are misnomers and should not be used. The preferred terms are glycosylamines and C-glycosyl compounds, respectively. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (26)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (3.85) | 18.2507 |
2000's | 4 (15.38) | 29.6817 |
2010's | 18 (69.23) | 24.3611 |
2020's | 3 (11.54) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 30.41
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (30.41) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 27 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |